R
Ronald Klein
Researcher at University of Wisconsin-Madison
Publications - 1306
Citations - 163459
Ronald Klein is an academic researcher from University of Wisconsin-Madison. The author has contributed to research in topics: Population & Diabetes mellitus. The author has an hindex of 194, co-authored 1305 publications receiving 149140 citations. Previous affiliations of Ronald Klein include Los Angeles Biomedical Research Institute & Wake Forest University.
Papers
More filters
Journal ArticleDOI
Aspirin Effects on Mortality and Morbidity in Patients With Diabetes Mellitus: Early Treatment Diabetic Retinopathy Study Report 14
Aaron Kassoff,Sheldon M. Buzney,J. Wallace McMeel,John J. Weiter,Gerald J. Doyle,Rodney L. Immerman,Gerald R. Friedman,Michael L. Klein,Richard F. Dreyer,Richard Chenoweth,Irvin Handelman,Richard Hohl,Robert Biesbroeck,Jack O. Sipperley,Charles A. Garcia,Michael A. Bloome,Richard S. Ruiz,F. Tempel Riekhof,William A. Bohart,Roy A. Goodart,Dana H. Clarke,David H. Orth,Timothy P. Flood,Kirk H. Packo,Jayant Malhotra,Akbar Rahmani,Edward J. Winter,Harish Bhatia,Robert P. Murphy,Stuart L. Fine,Michael J. Elman,Frederick L. Ferris,Thaddeus E. Prout,Arnall Patz,Thomas A. Rice,David Newsome,Lloyd M. Aiello,Lawrence I. Rand,S. Shah,Ramachandiran Cooppan,Jerry Cavallerano,Robert L. Poole,Philip Silver,Jose Briones,Mohammed Z. Wafai,Abdul C. Asmal,Rudolph M. Franklin,Laurence Arend,Donald Bergsma,Lance Turkish,Paul Beer,Denis Carroll,Edgar Thomas,Thomas C. Burton,Gary W. Abrams,Hak-Joong Kim,George A. Williams,Trexler M. Topping,Frederick H. Reeser,Thomas M. Aaberg,Gregory S. Brinton,James K. Kingham,Travis A. Meredith,Raymond R. Margherio,Patrick L. Murphy,Morton S. Cox,Michael T. Trese,Steven Winokur,Everett Ai,Robert Sorenson,Gary Arsham,John Cavender,Stanley M. Kopelow,Alan L. Shabo,Jose C. Briones,Richard D. Hornichter,Norman P. Blair,Morton F. Goldberg,C. Ronald Lindberg,Neil L. Ross,Lynn E. Hauser,Jose Cunha-Vaz,J. Terry Ernest,James C. Liang,Steven B. Cohen,Charles Vygantas,Gerald A. Williams,Harry W. Flynn,George W. Blankenship,William H. Knobloch,Robert C. Ramsay,Herbert L. Cantrill,Frederick C. Goetz,Byron J. Hoogwerf,José Berrocal,Raúl Pérez,A. Ramos Umpierre,James L. Kinyoun,Robert E. Kalina,Craig G. Wells,Steven V. Guzak,Jerry P. Palmer,Frank L. Myers,George H. Bresnick,Suresh R. Chandra,Matthew D. Davis,Ronald Klein,Thomas S. Stevens,Ingolf H. L. Wallow,Russell M. Dixon,Edward Ehrlich,Robin Ewart,Robert N. Frank,Stephenie Lucas,Fred W. Whitehouse,Harold B. Weiss,Ann E. Ballen,Michael Teske,Maria Warth,William E. Benson,William S. Tasman,Gary C. Brown,J. Archibald McNamara,Hunter L. Little,Robert L. Jack,Lawrence Basso,Dayton T. Miller,Elaine W. Gunter,David D. Bayse,W. Harry Hannon,James E. Myrick,Genell L. Knatterud,Marian R. Fisher,Mary Jane Prior,Franca Barton,Joseph A. Kufera,Thomas W. Miller,James K. Hooper,Richard S. Crow,Richard Baker,Ronald J. Prineas,Larry D. Hubbard,Yvonne L. Magli,Paul Segal,Richard L. Mowery,Emily Y. Chew,Daniel Seigel,Gary Cassel +147 more
TL;DR: The early treatment diabetic retinopathy study (ETDRS) as mentioned in this paper was a randomized clinical trial of aspirin vs placebo, which was sponsored by the National Eye Institute (NIEI).
Journal Article
Refractive status in the Beaver Dam Eye Study.
TL;DR: Cross-sectional data indicate age-related differences in refractive status in an adult population and suggest that education is associated with myopia independent of age.
Journal ArticleDOI
Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials
Nish Chaturvedi,Massimo Porta,Ronald Klein,Trevor J. Orchard,John H. Fuller,Hans-Henrik Parving,Rudy Bilous,Anne Katrin Sjølie +7 more
TL;DR: Although candesartan reduces the incidence of retinopathy, it did not see a beneficial effect on retInopathy progression, and the post-hoc outcome of at least a three-step increase for incidence yielded an HR of 0.65.
Journal ArticleDOI
Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial
Anne Katrin Sjølie,Ronald Klein,Massimo Porta,Trevor J. Orchard,John H. Fuller,Hans-Henrik Parving,Rudy Bilous,Nish Chaturvedi +7 more
TL;DR: Treatment with candesartan in type 2 diabetic patients with mild to moderate retinopathy might induce improvement ofretinopathy.
Identifying the Content Area for the 51-Item National Eye Institute Visual Function Questionnaire
Carol M. Mangione,Sandra H. Berry,Karen L. Spritzer,Nancy K. Janz,Ronald Klein,Cynthia Owsley,Paul P. Lee +6 more
TL;DR: In this paper, the content area for a questionnaire designed to measure vision-targeted health-related quality of life and to determine whether problems with vision-related functioning are qualitatively similar across different common eye diseases was identified.